Jefferies lowered the firm’s price target on Clorox (CLX) to $145 from $167 and keeps a Buy rating on the shares, telling investors that the next two quarters “will be complicated to model” as shipping timing ahead of Clorox’s U.S. ERP rollout and wind down will “create operating leverage and deleverage that surprises.” The firm, which expects Clorox to guide to down 4% to down 2% organic sales and a low-teens percentage EPS decline for FY26, thinks consensus estimates need a “recalibration” as numbers are “too high.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: